Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance

[...]with a well-validated risk scoring system (GRACE) that uses multiple risk components to predict mortality, a significant number of troponin-positive patients were found to be at low risk, and conversely, some troponin-negative patients were at high risk. 2 The guideline development group (GDG)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2010-10, Vol.96 (20), p.1662-1668
Hauptverfasser: Gray, Huon H, Henderson, Robert A, de Belder, Mark A, Underwood, S Richard, Camm, A John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1668
container_issue 20
container_start_page 1662
container_title Heart (British Cardiac Society)
container_volume 96
creator Gray, Huon H
Henderson, Robert A
de Belder, Mark A
Underwood, S Richard
Camm, A John
description [...]with a well-validated risk scoring system (GRACE) that uses multiple risk components to predict mortality, a significant number of troponin-positive patients were found to be at low risk, and conversely, some troponin-negative patients were at high risk. 2 The guideline development group (GDG) therefore recommended the use of a validated risk scoring system (such as GRACE (Global Registry of Acute Cardiac Events)) to determine risk in individual patients ( Box 2 ). The GRACE score is derived from a large cohort of unselected patients with ACS, it is available online ( http://www.outcomes-umassmed.org/grace/ , accessed August 2010), is easy to use and its components are an effective tool in an unselected UK population. 5 Box 1 Factors predicting adverse outcome in unstable angina/non-ST elevation myocardial infarction Advancing age Presence and severity of ECG changes of ischaemia Magnitude of rise in biomarkers of myocardial injury (eg, serum troponin) Left ventricular dysfunction Cardiogenic shock Increased heart rate Arrhythmias (ventricular, atrial fibrillation) Renal impairment Diabetes mellitus Anaemia Cerebrovascular disease Peripheral vascular disease Box 2 Global Registry of Cardiac Events (GRACE) risk score for in-hospital death with range of scores for each parameter in parentheses Age (0-100) Killip class (see below) (0-59) Heart rate (0-46) Systolic blood pressure (58-0) Serum creatinine (1-28) ST-segment deviation (28) Cardiac arrest at admission (39) Elevated serum cardiac enzymes (14) Total possible score =372 points GRACE risk score for death at 6 months with range of scores for each parameter in parentheses Age (0-100) Killip class (0-44) Heart rate (0-34) SBP (40-0) Serum creatinine (1-28) ST-segment deviation (17) Cardiac arrest at admission (30) Elevated serum cardiac enzymes (13) Total possible score =306 points NB:
doi_str_mv 10.1136/hrt.2010.204511
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759131539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>759131539</sourcerecordid><originalsourceid>FETCH-LOGICAL-b427t-9eb072bc7c634d5a4c2d6bf83d0811186bb4ef14c90633263783b0c5b692c62a3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Eou3CmRuKhFAlpLT-dtIbXW0_RFUOFIS4WGPHWbIkztZOEPvvcZqlSFw4zXjm8evxvAi9IviEECZPv4fhhOJ0opgLQp6gQ8JlkafS16cpZ0LkEjN1gI5i3GCMeVnI5-iA4pIpJcQh2q4gtLusAw9r1zk_ZH2djT4OYFqXgV83HlKoMt_7_NNdHt36gXKt-wlD0_us2_UWQtVAmzW-hmCn6lkWx66DsJvkbq-Xq2w9NhV4616gZzW00b3cxwX6fLG6W17lNx8vr5fvb3LDqRry0hmsqLHKSsYrAdzSSpq6YBUuCCGFNIa7mnBbYskYlUwVzGArjCyplRTYAh3PutvQ348uDrpronVtC971Y9RKlIQRwcpEvvmH3PRj8Gk4TVSBFcc0oQt0OlM29DEGV-ttaKYfaoL15IVOXujJCz17kW683uuOpnPVI_9n-Ql4uwcgWmjrkPbTxL8coyUlD0_nM9fEwf167EP4oaViSujbL0t9Lr6RC44_aJz4dzNvus1_p_wNa0utJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780740291</pqid></control><display><type>article</type><title>Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Gray, Huon H ; Henderson, Robert A ; de Belder, Mark A ; Underwood, S Richard ; Camm, A John</creator><creatorcontrib>Gray, Huon H ; Henderson, Robert A ; de Belder, Mark A ; Underwood, S Richard ; Camm, A John ; Guideline Development Group ; on behalf of the guideline development group (listed at the end)</creatorcontrib><description>[...]with a well-validated risk scoring system (GRACE) that uses multiple risk components to predict mortality, a significant number of troponin-positive patients were found to be at low risk, and conversely, some troponin-negative patients were at high risk. 2 The guideline development group (GDG) therefore recommended the use of a validated risk scoring system (such as GRACE (Global Registry of Acute Cardiac Events)) to determine risk in individual patients ( Box 2 ). The GRACE score is derived from a large cohort of unselected patients with ACS, it is available online ( http://www.outcomes-umassmed.org/grace/ , accessed August 2010), is easy to use and its components are an effective tool in an unselected UK population. 5 Box 1 Factors predicting adverse outcome in unstable angina/non-ST elevation myocardial infarction Advancing age Presence and severity of ECG changes of ischaemia Magnitude of rise in biomarkers of myocardial injury (eg, serum troponin) Left ventricular dysfunction Cardiogenic shock Increased heart rate Arrhythmias (ventricular, atrial fibrillation) Renal impairment Diabetes mellitus Anaemia Cerebrovascular disease Peripheral vascular disease Box 2 Global Registry of Cardiac Events (GRACE) risk score for in-hospital death with range of scores for each parameter in parentheses Age (0-100) Killip class (see below) (0-59) Heart rate (0-46) Systolic blood pressure (58-0) Serum creatinine (1-28) ST-segment deviation (28) Cardiac arrest at admission (39) Elevated serum cardiac enzymes (14) Total possible score =372 points GRACE risk score for death at 6 months with range of scores for each parameter in parentheses Age (0-100) Killip class (0-44) Heart rate (0-34) SBP (40-0) Serum creatinine (1-28) ST-segment deviation (17) Cardiac arrest at admission (30) Elevated serum cardiac enzymes (13) Total possible score =306 points NB:</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/hrt.2010.204511</identifier><identifier>PMID: 20937755</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>Acute coronary syndromes ; Angina, Unstable - therapy ; angina-unstable ; Angioplasty, Balloon, Coronary ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular Agents - therapeutic use ; Comorbidity ; Coronary heart disease ; Coronary vessels ; Electrocardiography ; Enzymes ; Evidence-Based Medicine ; Gangrene ; Heart ; Heart attacks ; Heart failure ; Heart rate ; Humans ; Intra-Aortic Balloon Pumping ; Medical imaging ; Medical sciences ; Molecular weight ; Mortality ; Myocardial Infarction - therapy ; Myocarditis ; Myocarditis. Cardiomyopathies ; Practice Guidelines as Topic ; Prevention ; Risk assessment ; Risk Assessment - methods</subject><ispartof>Heart (British Cardiac Society), 2010-10, Vol.96 (20), p.1662-1668</ispartof><rights>2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b427t-9eb072bc7c634d5a4c2d6bf83d0811186bb4ef14c90633263783b0c5b692c62a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://heart.bmj.com/content/96/20/1662.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://heart.bmj.com/content/96/20/1662.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,313,314,776,780,788,3183,23550,27899,27901,27902,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23292191$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20937755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gray, Huon H</creatorcontrib><creatorcontrib>Henderson, Robert A</creatorcontrib><creatorcontrib>de Belder, Mark A</creatorcontrib><creatorcontrib>Underwood, S Richard</creatorcontrib><creatorcontrib>Camm, A John</creatorcontrib><creatorcontrib>Guideline Development Group</creatorcontrib><creatorcontrib>on behalf of the guideline development group (listed at the end)</creatorcontrib><title>Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>[...]with a well-validated risk scoring system (GRACE) that uses multiple risk components to predict mortality, a significant number of troponin-positive patients were found to be at low risk, and conversely, some troponin-negative patients were at high risk. 2 The guideline development group (GDG) therefore recommended the use of a validated risk scoring system (such as GRACE (Global Registry of Acute Cardiac Events)) to determine risk in individual patients ( Box 2 ). The GRACE score is derived from a large cohort of unselected patients with ACS, it is available online ( http://www.outcomes-umassmed.org/grace/ , accessed August 2010), is easy to use and its components are an effective tool in an unselected UK population. 5 Box 1 Factors predicting adverse outcome in unstable angina/non-ST elevation myocardial infarction Advancing age Presence and severity of ECG changes of ischaemia Magnitude of rise in biomarkers of myocardial injury (eg, serum troponin) Left ventricular dysfunction Cardiogenic shock Increased heart rate Arrhythmias (ventricular, atrial fibrillation) Renal impairment Diabetes mellitus Anaemia Cerebrovascular disease Peripheral vascular disease Box 2 Global Registry of Cardiac Events (GRACE) risk score for in-hospital death with range of scores for each parameter in parentheses Age (0-100) Killip class (see below) (0-59) Heart rate (0-46) Systolic blood pressure (58-0) Serum creatinine (1-28) ST-segment deviation (28) Cardiac arrest at admission (39) Elevated serum cardiac enzymes (14) Total possible score =372 points GRACE risk score for death at 6 months with range of scores for each parameter in parentheses Age (0-100) Killip class (0-44) Heart rate (0-34) SBP (40-0) Serum creatinine (1-28) ST-segment deviation (17) Cardiac arrest at admission (30) Elevated serum cardiac enzymes (13) Total possible score =306 points NB:</description><subject>Acute coronary syndromes</subject><subject>Angina, Unstable - therapy</subject><subject>angina-unstable</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Agents - therapeutic use</subject><subject>Comorbidity</subject><subject>Coronary heart disease</subject><subject>Coronary vessels</subject><subject>Electrocardiography</subject><subject>Enzymes</subject><subject>Evidence-Based Medicine</subject><subject>Gangrene</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Heart rate</subject><subject>Humans</subject><subject>Intra-Aortic Balloon Pumping</subject><subject>Medical imaging</subject><subject>Medical sciences</subject><subject>Molecular weight</subject><subject>Mortality</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocarditis</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Practice Guidelines as Topic</subject><subject>Prevention</subject><subject>Risk assessment</subject><subject>Risk Assessment - methods</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhi0Eou3CmRuKhFAlpLT-dtIbXW0_RFUOFIS4WGPHWbIkztZOEPvvcZqlSFw4zXjm8evxvAi9IviEECZPv4fhhOJ0opgLQp6gQ8JlkafS16cpZ0LkEjN1gI5i3GCMeVnI5-iA4pIpJcQh2q4gtLusAw9r1zk_ZH2djT4OYFqXgV83HlKoMt_7_NNdHt36gXKt-wlD0_us2_UWQtVAmzW-hmCn6lkWx66DsJvkbq-Xq2w9NhV4616gZzW00b3cxwX6fLG6W17lNx8vr5fvb3LDqRry0hmsqLHKSsYrAdzSSpq6YBUuCCGFNIa7mnBbYskYlUwVzGArjCyplRTYAh3PutvQ348uDrpronVtC971Y9RKlIQRwcpEvvmH3PRj8Gk4TVSBFcc0oQt0OlM29DEGV-ttaKYfaoL15IVOXujJCz17kW683uuOpnPVI_9n-Ql4uwcgWmjrkPbTxL8coyUlD0_nM9fEwf167EP4oaViSujbL0t9Lr6RC44_aJz4dzNvus1_p_wNa0utJg</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Gray, Huon H</creator><creator>Henderson, Robert A</creator><creator>de Belder, Mark A</creator><creator>Underwood, S Richard</creator><creator>Camm, A John</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20101001</creationdate><title>Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance</title><author>Gray, Huon H ; Henderson, Robert A ; de Belder, Mark A ; Underwood, S Richard ; Camm, A John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b427t-9eb072bc7c634d5a4c2d6bf83d0811186bb4ef14c90633263783b0c5b692c62a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acute coronary syndromes</topic><topic>Angina, Unstable - therapy</topic><topic>angina-unstable</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Agents - therapeutic use</topic><topic>Comorbidity</topic><topic>Coronary heart disease</topic><topic>Coronary vessels</topic><topic>Electrocardiography</topic><topic>Enzymes</topic><topic>Evidence-Based Medicine</topic><topic>Gangrene</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Heart rate</topic><topic>Humans</topic><topic>Intra-Aortic Balloon Pumping</topic><topic>Medical imaging</topic><topic>Medical sciences</topic><topic>Molecular weight</topic><topic>Mortality</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocarditis</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Practice Guidelines as Topic</topic><topic>Prevention</topic><topic>Risk assessment</topic><topic>Risk Assessment - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gray, Huon H</creatorcontrib><creatorcontrib>Henderson, Robert A</creatorcontrib><creatorcontrib>de Belder, Mark A</creatorcontrib><creatorcontrib>Underwood, S Richard</creatorcontrib><creatorcontrib>Camm, A John</creatorcontrib><creatorcontrib>Guideline Development Group</creatorcontrib><creatorcontrib>on behalf of the guideline development group (listed at the end)</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gray, Huon H</au><au>Henderson, Robert A</au><au>de Belder, Mark A</au><au>Underwood, S Richard</au><au>Camm, A John</au><aucorp>Guideline Development Group</aucorp><aucorp>on behalf of the guideline development group (listed at the end)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>96</volume><issue>20</issue><spage>1662</spage><epage>1668</epage><pages>1662-1668</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>[...]with a well-validated risk scoring system (GRACE) that uses multiple risk components to predict mortality, a significant number of troponin-positive patients were found to be at low risk, and conversely, some troponin-negative patients were at high risk. 2 The guideline development group (GDG) therefore recommended the use of a validated risk scoring system (such as GRACE (Global Registry of Acute Cardiac Events)) to determine risk in individual patients ( Box 2 ). The GRACE score is derived from a large cohort of unselected patients with ACS, it is available online ( http://www.outcomes-umassmed.org/grace/ , accessed August 2010), is easy to use and its components are an effective tool in an unselected UK population. 5 Box 1 Factors predicting adverse outcome in unstable angina/non-ST elevation myocardial infarction Advancing age Presence and severity of ECG changes of ischaemia Magnitude of rise in biomarkers of myocardial injury (eg, serum troponin) Left ventricular dysfunction Cardiogenic shock Increased heart rate Arrhythmias (ventricular, atrial fibrillation) Renal impairment Diabetes mellitus Anaemia Cerebrovascular disease Peripheral vascular disease Box 2 Global Registry of Cardiac Events (GRACE) risk score for in-hospital death with range of scores for each parameter in parentheses Age (0-100) Killip class (see below) (0-59) Heart rate (0-46) Systolic blood pressure (58-0) Serum creatinine (1-28) ST-segment deviation (28) Cardiac arrest at admission (39) Elevated serum cardiac enzymes (14) Total possible score =372 points GRACE risk score for death at 6 months with range of scores for each parameter in parentheses Age (0-100) Killip class (0-44) Heart rate (0-34) SBP (40-0) Serum creatinine (1-28) ST-segment deviation (17) Cardiac arrest at admission (30) Elevated serum cardiac enzymes (13) Total possible score =306 points NB:</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>20937755</pmid><doi>10.1136/hrt.2010.204511</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1355-6037
ispartof Heart (British Cardiac Society), 2010-10, Vol.96 (20), p.1662-1668
issn 1355-6037
1468-201X
language eng
recordid cdi_proquest_miscellaneous_759131539
source MEDLINE; BMJ Journals - NESLi2; PubMed Central
subjects Acute coronary syndromes
Angina, Unstable - therapy
angina-unstable
Angioplasty, Balloon, Coronary
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular Agents - therapeutic use
Comorbidity
Coronary heart disease
Coronary vessels
Electrocardiography
Enzymes
Evidence-Based Medicine
Gangrene
Heart
Heart attacks
Heart failure
Heart rate
Humans
Intra-Aortic Balloon Pumping
Medical imaging
Medical sciences
Molecular weight
Mortality
Myocardial Infarction - therapy
Myocarditis
Myocarditis. Cardiomyopathies
Practice Guidelines as Topic
Prevention
Risk assessment
Risk Assessment - methods
title Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T00%3A15%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20management%20of%20unstable%20angina%20and%20non-ST-segment%20elevation%20myocardial%20infarction:%20summary%20of%20NICE%20guidance&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Gray,%20Huon%20H&rft.aucorp=Guideline%20Development%20Group&rft.date=2010-10-01&rft.volume=96&rft.issue=20&rft.spage=1662&rft.epage=1668&rft.pages=1662-1668&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/hrt.2010.204511&rft_dat=%3Cproquest_cross%3E759131539%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780740291&rft_id=info:pmid/20937755&rfr_iscdi=true